Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: COVID-19; This is a spontaneous report received from a contactable physician, downloaded from the Regulatory Authority NL-LRB-00444454. A 90-year-old female patient received bnt162b2 (COMIRNATY) (Lot # EJ6134), via an unspecified route of administration at single dose on 29Jan2021 for covid-19 immunisation. Medical history included ongoing chronic obstructive pulmonary disease, ongoing emphysema. Concomitant medication included midazolam, morfine. The patient experienced Covid-19 on 06Feb2021 with fatal outcome. The patient died on 12Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 06Feb2021. It was not reported if an autopsy was performed. The patient died at home using palliative sedation as a result of complications from Covid-19. Unknown if there was a relationship with vaccination with Comirnaty. Clinical course as follows: 5 days after vaccination, the patient experienced symptoms of a Covid-19 infection, 8 days after vaccinations the patient had a positive SARS COV 2 test and 14 days after vaccination the patient deceased with palliative sedation. The patient died of complications of a Covid-19 infection. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: complications of COVID19
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166